<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Brain</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Brain</journal-id>
<journal-title-group>
<journal-title>Molecular Brain</journal-title>
</journal-title-group>
<issn pub-type="epub">1756-6606</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28982363</article-id>
<article-id pub-id-type="pmc">5629790</article-id>
<article-id pub-id-type="publisher-id">328</article-id>
<article-id pub-id-type="doi">10.1186/s13041-017-0328-5</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Abnormalities in perineuronal nets and behavior in mice lacking CSGalNAcT1, a key enzyme in chondroitin sulfate synthesis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yoshioka</surname>
<given-names>Nozomu</given-names>
</name>
<address>
<email>nzyoshioka@med.niigata-u.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miyata</surname>
<given-names>Shinji</given-names>
</name>
<address>
<email>miyata@agr.nagoya-u.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tamada</surname>
<given-names>Atsushi</given-names>
</name>
<address>
<email>tamada@med.niigata-u.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Watanabe</surname>
<given-names>Yumi</given-names>
</name>
<address>
<email>ywatana@med.niigata-u.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kawasaki</surname>
<given-names>Asami</given-names>
</name>
<address>
<email>akawasaki@med.niigata-u.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kitagawa</surname>
<given-names>Hiroshi</given-names>
</name>
<address>
<email>kitagawa@kobepharma-u.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Takao</surname>
<given-names>Keizo</given-names>
</name>
<address>
<email>takao@cts.u-toyama.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff6">6</xref>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miyakawa</surname>
<given-names>Tsuyoshi</given-names>
</name>
<address>
<email>miyakawa@fujita-hu.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff6">6</xref>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Takeuchi</surname>
<given-names>Kosei</given-names>
</name>
<address>
<email>koseitak@aichi-med-u.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1474-3385</contrib-id>
<name>
<surname>Igarashi</surname>
<given-names>Michihiro</given-names>
</name>
<address>
<phone>+81-25-227-2083</phone>
<email>tarokaja@med.niigata-u.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0671 5144</institution-id><institution-id institution-id-type="GRID">grid.260975.f</institution-id><institution>Department of Neurochemistry and Molecular Cell Biology, </institution><institution>Niigata University Graduate School of Medical and Dental Sciences, </institution></institution-wrap>1-757 Asahimachi, Chuo-ku, Niigata, 951-8510 Japan </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0671 5144</institution-id><institution-id institution-id-type="GRID">grid.260975.f</institution-id><institution>Transdiciplinary Research Program, </institution><institution>Niigata University, </institution></institution-wrap>Asahi-machi, Niigata, 951-8510 Japan </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0371 6549</institution-id><institution-id institution-id-type="GRID">grid.411100.5</institution-id><institution>Department of Biochemistry, </institution><institution>Kobe Pharmaceutical University, </institution></institution-wrap>Motoyamakita-machi, Kobe, 658-8558 Japan </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0943 978X</institution-id><institution-id institution-id-type="GRID">grid.27476.30</institution-id><institution>Institute for Advanced Research, </institution><institution>Nagoya University, </institution></institution-wrap>Furo-cho, Nagoya, 464-8601 Japan </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1754 9200</institution-id><institution-id institution-id-type="GRID">grid.419082.6</institution-id><institution>PRESTO, Japan Science and Technology Agency (JST), </institution></institution-wrap>Chiyoda-ku, Tokyo, 102-0075 Japan </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI"> 0000 0001 2272 1771</institution-id><institution-id institution-id-type="GRID">grid.467811.d</institution-id><institution>Section of Behavior Patterns, National Institute of Physiological Sciences, </institution></institution-wrap>Okazaki, Aichi 444-8787 Japan </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2171 836X</institution-id><institution-id institution-id-type="GRID">grid.267346.2</institution-id><institution>Division of Experimental Animal Resource and Development, Life Science Research Center, </institution><institution>Toyama University, </institution></institution-wrap>Toyama, 930-0194 Japan </aff>
<aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1761 798X</institution-id><institution-id institution-id-type="GRID">grid.256115.4</institution-id><institution>Division of Systems Medical Science, Institute for Comprehensive Medical Science, </institution><institution>Fujita Health University, </institution></institution-wrap>Toyoake, Aichi 470-1192 Japan </aff>
<aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0727 1557</institution-id><institution-id institution-id-type="GRID">grid.411234.1</institution-id><institution>Department of Medical Biology, School of Medicine, </institution><institution>Aichi Medical University, </institution></institution-wrap>Nagakute, Aichi 480-1103 Japan </aff>
<aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0671 5144</institution-id><institution-id institution-id-type="GRID">grid.260975.f</institution-id><institution>Present address: Divisions of Neurobiology and Anatomy, </institution><institution>Niigata University Graduate School of Medical and Dental Sciences, </institution></institution-wrap>Niigata, Japan </aff>
<aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0671 5144</institution-id><institution-id institution-id-type="GRID">grid.260975.f</institution-id><institution>Present address: Divisions of Preventive Medicine, </institution><institution>Niigata University Graduate School of Medical and Dental Sciences, </institution></institution-wrap>Niigata, Japan </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>5</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>5</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>10</volume>
<elocation-id>47</elocation-id>
<history>
<date date-type="received">
<day>7</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>9</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Â© The Author(s). 2017</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Chondroitin sulfate (CS) is an important glycosaminoglycan and is mainly found in the extracellular matrix as CS proteoglycans. In the brain, CS proteoglycans are highly concentrated in perineuronal nets (PNNs), which surround synapses and modulate their functions. To investigate the importance of CS, we produced and precisely examined mice that were deficient in the CS synthesizing enzyme, CSGalNAcT1 (T1KO). Biochemical analysis of T1KO revealed that loss of this enzyme reduced the amount of CS by approximately 50% in various brain regions. The amount of CS in PNNs was also diminished in T1KO compared to wild-type mice, although the amount of a major CS proteoglycan core protein, aggrecan, was not changed. In T1KO, we observed abnormalities in several behavioral tests, including the open-field test, acoustic startle response, and social preference. These results suggest that T1 is important for plasticity, probably due to regulation of CS-dependent PNNs, and that T1KO is a good model for investigation of PNNs.</p>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1186/s13041-017-0328-5) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<funding-group>
<award-group>
<funding-source>
<institution>KAKENHI</institution>
</funding-source>
<award-id>#17023019, #22240040, and #24111515</award-id>
<principal-award-recipient>
<name>
<surname>Igarashi</surname>
<given-names>Michihiro</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group>
<funding-source>
<institution>Sasakawa Scientific Research Grant </institution>
</funding-source>
</award-group>
<award-group>
<funding-source>
<institution>Platform of Advanced Animal Model Support from MEXT of Japan</institution>
</funding-source>
</award-group>
<award-group>
<funding-source>
<institution>Uehara Memorial Science Promoting Foundation</institution>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>Â© The Author(s) 2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par2">Chondroitin sulfate (CS) is one of the most abundant glycosaminoglycans, which are composed of long, repeated disaccharide chains. For synthesis of CS proteoglycans (CSPGs), CS is attached to core proteins, such as aggrecan (AGR), neurocan, phosphacan, and versican. These CSPGs are mainly localized in the extracellular matrix. In the central nervous system, CSPG-enriched areas are called perineuronal nets (PNNs), which are specialized structures that surround synapses and are specifically recognized by <italic>Wisteria floribunda</italic> lectin (WFA). PNNs modulate synaptic functions, particularly GABAergic inhibitory input via parvalbumin (PV) (+) neuronal cells [<xref ref-type="bibr" rid="CR1">1</xref>]. Recently, the function of PNNs in the regulation of synaptic plasticity and memory [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>] has been investigated, and PNN abnormalities in relation to human mental diseases have been reported [<xref ref-type="bibr" rid="CR4">4</xref>â<xref ref-type="bibr" rid="CR6">6</xref>].</p>
<p id="Par3">CS synthesis is sequentially performed by approximately 15 enzymes including glycosyltransferases and sulfotransferases in three steps: (I) tetrasaccharide linker synthesis attached to the core protein; (II) disaccharide repeat synthesis for GalNAc (<italic>N</italic>-acetylgalactosamine)-GlcUA (glucuronic acid); and (III) sulfation of these sugars. The first step is shared with another glycosaminoglycan, heparan sulfate; thus, the first unique step in CS synthesis is GalNAc transfer to the linker. CSGalNAcT1 (T1) is a key enzyme in CS synthesis, because this enzyme catalyzes the first unique step in CS synthesis, apart from heparan sulfate synthesis.</p>
<p id="Par4">We previously produced T1 knockout mice (T1KO; [CSGalNAcT1<sup>â/â</sup>] mice) and examined some functions of CS [<xref ref-type="bibr" rid="CR7">7</xref>]. T1KO mice have impaired bone development and a 10% smaller body size than wild-type (WT) mice [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. They have the striking feature of rapid recovery following spinal cord injury [<xref ref-type="bibr" rid="CR9">9</xref>]. During recovery from spinal cord injury in T1KO, we observed a loss of PNNs in the spinal cord [<xref ref-type="bibr" rid="CR9">9</xref>], suggesting abnormal PNN formation.</p>
<p id="Par5">Here, we systematically examined the T1KO brain. Biochemically, the amount of CS was reduced by about half in each region in T1KO brain. Histologically, abnormal PNNs due to reduced CS were observed, and the mice demonstrated abnormal behaviors in several tests. Taken together, we conclude that T1 plays an important role in supplying CS for PNN development and brain functions related to several characteristic behaviors.</p>
</sec>
<sec id="Sec2">
<title>Results</title>
<sec id="Sec3">
<title>Biochemical and histochemical characteristics of T1KO</title>
<p id="Par6">T1KO mice were fertile and showed no macroscopic abnormalities in the brain. However, various regions of the brain had only 50% of the amount of CS compared to WT, including significant differences in the cortex and diencephalon (Fig.Â <xref ref-type="fig" rid="Fig1">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>T1KO had half the amount of CS compared to WT in various brain regions. The total amount of CS in WT (<italic>closed bars</italic>) and in T1KO (<italic>open bars</italic>) is shown. The mice used were 12Â week-old males. Data are the meanÂ Â±Â SEM. *<italic>p</italic>Â &lt;Â 0.05; ***<italic>p</italic>Â &lt;Â 0.001; <italic>n.s.</italic>, not significant. <italic>N</italic>Â =Â 3â4 mice each</p></caption><graphic id="MO1" xlink:href="13041_2017_328_Fig1_HTML"></graphic></fig>
</p>
<p id="Par7">Disaccharide compositions were also analyzed, and among five disaccharide patterns of CS (ref. 16; i.e., CS-O, âA, âC, âD, and -E) [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR10">10</xref>], we observed a slight but significant increase in the CS-E ratio in both the cortex and diencephalon of the T1KO (TableÂ <xref ref-type="table" rid="Tab1">1</xref>). These results suggest that T1KO is an important enzyme for CS synthesis in the brain. Microscopic abnormalities in T1KO brain.<table-wrap id="Tab1"><label>Table 1</label><caption><p>The composition of CS disaccharides in T1KO compared with WT</p></caption><table frame="hsides" rules="groups"><thead><tr><th>mol%</th><th>Average</th><th>SEM</th><th>Average</th><th>SEM</th><th>
<italic>P</italic> value</th></tr></thead><tbody><tr><td>Cerebrum</td><td align="center" colspan="2">WT</td><td align="center" colspan="2">KO</td><td></td></tr><tr><td>âO</td><td>9.1</td><td>0.19</td><td>12.0</td><td>1.04</td><td>
<italic>0.046</italic>
</td></tr><tr><td>âC</td><td>1.8</td><td>0.27</td><td>5.3</td><td>0.12</td><td>0.821</td></tr><tr><td>âA</td><td>87.2</td><td>0.14</td><td>77.7</td><td>0.69</td><td>
<italic>0.027</italic>
</td></tr><tr><td>âD</td><td>0.7</td><td>0.05</td><td>2.1</td><td>0.03</td><td>
<italic>0.003</italic>
</td></tr><tr><td>âE</td><td>1.2</td><td>0.05</td><td>2.9</td><td>0.44</td><td>
<italic>0.001</italic>
</td></tr><tr><td>âTotal</td><td>100.0</td><td></td><td>100.0</td><td></td><td></td></tr><tr><td>Diencephalon</td><td align="center" colspan="2">WT</td><td align="center" colspan="2">KO</td><td></td></tr><tr><td>âO</td><td>4.4</td><td>0.17</td><td>4.7</td><td>0.25</td><td>0.374</td></tr><tr><td>âC</td><td>3.8</td><td>0.09</td><td>3.0</td><td>0.06</td><td>
<italic>0.002</italic>
</td></tr><tr><td>âA</td><td>88.9</td><td>0.34</td><td>89.4</td><td>0.34</td><td>0.367</td></tr><tr><td>âD</td><td>1.3</td><td>0.13</td><td>1.0</td><td>0.03</td><td>0.075</td></tr><tr><td>âE</td><td>1.6</td><td>0.05</td><td>1.9</td><td>0.06</td><td>
<italic>0.030</italic>
</td></tr><tr><td>âTotal</td><td>100.0</td><td></td><td>100.0</td><td></td><td></td></tr><tr><td>Cerebellum</td><td align="center" colspan="2">WT</td><td align="center" colspan="2">KO</td><td></td></tr><tr><td>âO</td><td>7.6</td><td>1.88</td><td>4.5</td><td>0.24</td><td>0.183</td></tr><tr><td>âC</td><td>3.7</td><td>0.17</td><td>4.9</td><td>0.43</td><td>0.062</td></tr><tr><td>âA</td><td>85.5</td><td>1.52</td><td>87.3</td><td>0.46</td><td>0.333</td></tr><tr><td>âD</td><td>1.8</td><td>0.20</td><td>1.6</td><td>0.12</td><td>0.395</td></tr><tr><td>âE</td><td>1.4</td><td>0.01</td><td>1.7</td><td>0.15</td><td>0.082</td></tr><tr><td>âTotal</td><td>100.0</td><td></td><td>100.0</td><td></td><td></td></tr><tr><td>Spinal Cord</td><td align="center" colspan="2">WT</td><td align="center" colspan="2">KO</td><td></td></tr><tr><td>âO</td><td>12.0</td><td>1.04</td><td>11.8</td><td>2.68</td><td>0.930</td></tr><tr><td>âC</td><td>5.3</td><td>0.12</td><td>4.7</td><td>0.06</td><td>
<italic>0.041</italic>
</td></tr><tr><td>âA</td><td>77.7</td><td>0.69</td><td>78.7</td><td>2.27</td><td>0.647</td></tr><tr><td>âD</td><td>2.1</td><td>0.03</td><td>1.4</td><td>0.25</td><td>
<italic>0.036</italic>
</td></tr><tr><td>âE</td><td>2.9</td><td>0.44</td><td>3.4</td><td>0.59</td><td>0.525</td></tr><tr><td>âTotal</td><td>100.0</td><td></td><td>100.0</td><td></td><td></td></tr><tr><td>Visual Cortex</td><td align="center" colspan="2">WT</td><td align="center" colspan="2">KO</td><td></td></tr><tr><td>âO</td><td>9.0</td><td>0.18</td><td>10.7</td><td>0.16</td><td>
<italic>4E-04</italic>
</td></tr><tr><td>âC</td><td>2.7</td><td>0.01</td><td>2.3</td><td>0.03</td><td>
<italic>3E-05</italic>
</td></tr><tr><td>âA</td><td>86.4</td><td>0.18</td><td>84.6</td><td>0.19</td><td>
<italic>5E-04</italic>
</td></tr><tr><td>âD</td><td>0.7</td><td>0.03</td><td>0.4</td><td>0.03</td><td>
<italic>4E-04</italic>
</td></tr><tr><td>âE</td><td>1.2</td><td>0.01</td><td>1.9</td><td>0.03</td><td>
<italic>5E-07</italic>
</td></tr><tr><td>âTotal</td><td>100.0</td><td></td><td>100.0</td><td></td><td></td></tr></tbody></table><table-wrap-foot><p>Note that among the five patterns of CS-derived disaccharides, CS-E in T1KO was significantly increased in each brain region. Statistically significant differences in T1KO are shown in italics (<italic>p</italic>Â &lt;Â 0.05), compared to the corresponding results for WT [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]</p></table-wrap-foot></table-wrap>
</p>
<p id="Par8">Next, we examined whether microscopic abnormalities were found in T1KO brain. Because high levels of CS should be detected in PNNs of WT, we histochemically examined WFA-labeled PNNs using diaminobenzidine (DAB) staining and fluorescent studies. DAB staining of WFA, which represents PNNs, showed that PNNs were largely reduced in the cingulate cortex of T1KO (Fig.Â <xref ref-type="fig" rid="Fig2">2a, b, e-f</xref>), and to some extent in the somatosensory cortex of T1KO (Fig.Â <xref ref-type="fig" rid="Fig2">2d and h</xref>). Using 2H6, an antibody against CS that also tends to label extracellular matrix other than PNNs, we confirmed that CS staining in such areas was much reduced (Fig.Â <xref ref-type="fig" rid="Fig2">2c and g</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Representative views of histochemistry revealed abnormal PNNs but normal PV cells and AGR distribution in various brain regions. <bold>a-p</bold> DAB staining of CS in the cingulate cortex (CCX; WT; <bold>a-c,</bold> T1KO; <bold>e-g</bold>) and in the somatosensory cortex (SCX; WT: <bold>d</bold>, T1KO: <bold>h</bold>). <bold>b</bold> and <bold>f</bold> are higher magnification views of the rectangular areas in (<bold>a)</bold> and (<bold>e</bold>)<bold>,</bold> respectively. CS was labeled with WFA (<bold>a, b, d, e, f, h</bold>), and directly recognized with an anti-CS antibody, 2H6 (<bold>c, g</bold>). <bold>i-p</bold> Triple fluorescent staining with WFA (<italic>green</italic>), anti-AGR (<italic>red</italic>), and anti-PV (<italic>blue</italic>) in the CCX (<bold>i, m</bold>), SCX (<bold>j, n</bold>), hippocampus (HI) (<bold>k, o</bold>), and thalamic reticular nucleus (TRN) (<bold>l, p</bold>) in the brain obtained from WT (<bold>i-l</bold>) and T1KO (<bold>m-p</bold>) mice. Representative PV cells were indicated by <italic>white arrows</italic> (<bold>i-p</bold>). Scale bars, 200Â Î¼m (<bold>a</bold> and <bold>e</bold>), 50Â Î¼m (<bold>b-d, f-h</bold>), and 100Â Î¼m (<bold>i-p</bold>)</p></caption><graphic id="MO2" xlink:href="13041_2017_328_Fig2_HTML"></graphic></fig>
</p>
<p id="Par9">We quantitatively analyzed WFA, anti-AGR, and anti-PV immunofluorescence by assessing the intensity (Fig.Â <xref ref-type="fig" rid="Fig2">2i-p</xref>) following triple fluorescent staining. Somatosensory cortex showed a reduction in WFA (+) PNNs (Fig.Â <xref ref-type="fig" rid="Fig2">2i and m</xref>), but the intensities of anti-AGR and anti-PV immunofluorescence, which is thought to represent the amounts of AGR in PNNs and PV (+) cells, respectively, were not different in T1KO (Fig.Â <xref ref-type="fig" rid="Fig2">2m</xref>). We observed similar patterns in the cingulate cortex (Fig.Â <xref ref-type="fig" rid="Fig2">2j and n</xref>), hippocampus (Fig.Â <xref ref-type="fig" rid="Fig2">2k and o</xref>), and thalamic reticular nucleus of the T1KO (Fig.Â <xref ref-type="fig" rid="Fig2">2l and p</xref>). These results suggest that T1KO have reduced CS in PNNs but the core proteins remain, independent of CS.</p>
<p id="Par10">Quantitative analysis of these fluorescent results (Fig.Â <xref ref-type="fig" rid="Fig2">2i-p</xref>) confirmed this observation (Fig.Â <xref ref-type="fig" rid="Fig3">3</xref>). In all examined areas in T1KO, the intensities of anti-AGR and anti-PV were not changed, but the intensity ratios of WFA (+) PNNs per AGR (+) area were selectively decreased (Fig.Â <xref ref-type="fig" rid="Fig3">3</xref>). We also confirmed that AGR immunoreactivity was not changed between brains of WT and T1KO using immunoblotting (Additional fileÂ <xref ref-type="media" rid="MOESM1">1</xref> Figure S1).<fig id="Fig3"><label>Fig. 3</label><caption><p>Quantitative analysis of the histochemistry. <bold>a-c</bold> Intensity analyses of AGR (<bold>a</bold>), WFA (<bold>b</bold>), and PV (<bold>c</bold>) relative to AGR (+) pixels. The average intensity on each section was calculated. <italic>Open bars</italic>, WT; <italic>Closed bars</italic>, T1KO. The data represent the meanÂ Â±Â SD. RN, red nucleus; DCN, deep cerebellar nucleus. See Fig.Â <xref ref-type="fig" rid="Fig2">2</xref> for other abbreviations. The number of samples for each data point is shown at the bottom of the column. **<italic>p</italic>Â &lt;Â 0.01; ****<italic>p</italic>Â &lt;Â 0.0001; <italic>n.s.</italic>, not significant. Bonferroni post-hoc tests after two-way factorial ANOVA</p></caption><graphic id="MO3" xlink:href="13041_2017_328_Fig3_HTML"></graphic></fig>
</p>
</sec>
<sec id="Sec4">
<title>Behavioral abnormalities in T1KO</title>
<p id="Par11">We performed a battery of more than 20 behavioral tests and found the following abnormalities in T1KO compared to WT: general health (body weight), open field test, rota-rod test, acoustic startle responses, general activity, and social preference (stay time) (Fig.Â <xref ref-type="fig" rid="Fig4">4</xref>). The total distance traveled in the open field test, which measures voluntary activity in a novel environment, was significantly higher in T1KO than WT, suggesting that T1KO showed hyperlocomotive activity. Acoustic startle tests, which measure reflex movement when a sudden loud sound stimulus is given, revealed that T1KO had much larger responses than WT. In contrast, other tests including learning and memory were not impaired (TableÂ <xref ref-type="table" rid="Tab2">2</xref>). These results suggest that T1KO show several abnormal behaviors that involve higher brain functions, probably due to the reduced CS concentration in PNNs.<fig id="Fig4"><label>Fig. 4</label><caption><p>Behavioral abnormalities in T1KO. Significant differences were observed between genotypes in the six behavioral tests shown here. <bold>a</bold> General health (body weight; ****<italic>p</italic>Â &lt;Â 0.0001), <bold>b</bold> Open field test (**<italic>p</italic>Â &lt;Â 0.05), (<bold>c</bold>) Rota-rod test (**<italic>p</italic>Â &lt;Â 0.05), <bold>d</bold> Acoustic startle responses (**<italic>p</italic>Â &lt;Â 0.05), <bold>e</bold> General activity (**<italic>p</italic>Â &lt;Â 0.05; ***<italic>p</italic>Â &lt;Â 0.001), and <bold>f</bold> Social preference (stay time) (**<italic>p</italic>Â &lt;Â 0.05; ***<italic>p</italic>Â &lt;Â 0.001; ****<italic>p</italic>Â &lt;Â 0.0001). Each group was composed of 20 male mice at the age of 12Â weeks. See also TableÂ <xref ref-type="table" rid="Tab2">2</xref>
</p></caption><graphic id="MO4" xlink:href="13041_2017_328_Fig4_HTML"></graphic></fig>
<table-wrap id="Tab2"><label>Table 2</label><caption><p>The behavioral tests in T1KO that were not significantly different between genotypes (<italic>p</italic>Â â¥Â 0.05)</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Test</th><th colspan="2">Controls</th><th colspan="2">Mutants</th><th rowspan="2">F value</th><th rowspan="2">
<italic>p</italic> value</th></tr><tr><th>Mean</th><th>SEM</th><th>Mean</th><th>SEM</th></tr></thead><tbody><tr><td colspan="7">General health/neurological screen</td></tr><tr><td>âbody temperature (Â°C)</td><td>36.85</td><td>0.141</td><td>37.28</td><td>0.164</td><td>2.747</td><td>0.1049</td></tr><tr><td>âgrip strength (n)</td><td>0.554</td><td>0.02</td><td>0.577</td><td>0.012</td><td>1.038</td><td>0.3141</td></tr><tr><td>âwire hang (latency to fall, s)</td><td>39.512</td><td>5.428</td><td>29.507</td><td>2.879</td><td>3.204</td><td>0.0808</td></tr><tr><td colspan="7">Light/dark transition</td></tr><tr><td>âlatency to light (s)</td><td>44.143</td><td>5.829</td><td>56.1</td><td>6.621</td><td>1.293</td><td>0.2619</td></tr><tr><td>âlight distance (cm)</td><td>622.129</td><td>46.667</td><td>609.563</td><td>41.119</td><td>0.034</td><td>0.8548</td></tr><tr><td>âdark distance (cm)</td><td>1555.886</td><td>65.493</td><td>1628.983</td><td>35.355</td><td>1.147</td><td>0.2904</td></tr><tr><td>ânumber of transitions</td><td>32.714</td><td>2.23</td><td>28.967</td><td>1.965</td><td>1.32</td><td>0.2571</td></tr><tr><td>âstay time in light (s)</td><td>158.071</td><td>9.869</td><td>147.5</td><td>10.065</td><td>0.423</td><td>0.5189</td></tr><tr><td colspan="7">Open field</td></tr><tr><td>âstereotypic counts</td><td>6911.643</td><td>520.353</td><td>7369.367</td><td>526.983</td><td>0.289</td><td>0.5939</td></tr><tr><td>âvertical activity</td><td>348.357</td><td>53.683</td><td>275.4</td><td>43.994</td><td>0.966</td><td>0.3312</td></tr><tr><td>âcenter time (s)</td><td>633.986</td><td>121.934</td><td>813.077</td><td>111.923</td><td>0.945</td><td>0.3365</td></tr><tr><td colspan="7">Elevated plus maze</td></tr><tr><td>ânumber of total entry (times)</td><td>36.071</td><td>2.319</td><td>36.833</td><td>2.229</td><td>0.044</td><td>0.835</td></tr><tr><td>âentry into open arms (%)</td><td>13.393</td><td>2.567</td><td>13.863</td><td>1.572</td><td>0.027</td><td>0.8715</td></tr><tr><td>âtotal distance travelled (cm)</td><td>1806.893</td><td>92.545</td><td>1880.087</td><td>73.559</td><td>0.343</td><td>0.5614</td></tr><tr><td>âtime on open arms (times)</td><td>3.443</td><td>1.125</td><td>2.923</td><td>0.744</td><td>0.152</td><td>0.6985</td></tr><tr><td colspan="7">Hot plate</td></tr><tr><td>âlatency (s)</td><td>6.403</td><td>0.386</td><td>6.318</td><td>0.394</td><td>0.018</td><td>0.8944</td></tr><tr><td colspan="7">Social interaction (novel environment)</td></tr><tr><td>âduration of contacts (s)</td><td>68.7</td><td>9.138</td><td>88.707</td><td>7.29</td><td>2.605</td><td>0.1222</td></tr><tr><td>ânumber or contacts (times)</td><td>40.143</td><td>3.845</td><td>45.333</td><td>2.462</td><td>1.358</td><td>0.2577</td></tr><tr><td>âmean duration of contacts (s)</td><td>1.786</td><td>0.263</td><td>1.993</td><td>0.187</td><td>0.4</td><td>0.5341</td></tr><tr><td>âdistance travelled (cm)</td><td>2957.586</td><td>285.871</td><td>3196.793</td><td>153.133</td><td>0.654</td><td>0.4283</td></tr><tr><td colspan="7">Porsolt forced swim</td></tr><tr><td>âday1 immobility (%)</td><td>41.8131</td><td>3.617</td><td>46.252</td><td>2.314</td><td>1.099</td><td>0.3009</td></tr><tr><td>âday2 immobility (%)</td><td>57.747</td><td>3.627</td><td>54.268</td><td>2.624</td><td>0.569</td><td>0.4551</td></tr><tr><td colspan="7">Gait analysis</td></tr><tr><td>âfront swing/stride duration</td><td>41</td><td>0.508</td><td>40.969</td><td>0.43</td><td>0.002</td><td>0.9662</td></tr><tr><td>âfront brake/stride duration</td><td>28.115</td><td>0.909</td><td>27.234</td><td>0.715</td><td>0.512</td><td>0.4784</td></tr><tr><td>âfront propel/stride duration</td><td>30.896</td><td>0.871</td><td>31.795</td><td>0.645</td><td>0.635</td><td>0.4302</td></tr><tr><td>âfront stance width</td><td>1.946</td><td>0.062</td><td>1.921</td><td>0.038</td><td>0.134</td><td>0.7164</td></tr><tr><td>âfront step angle</td><td>62.308</td><td>1.762</td><td>60.066</td><td>1.075</td><td>1.269</td><td>0.2666</td></tr><tr><td>âfront paw angle</td><td>â0.235</td><td>0.866</td><td>0.89</td><td>0.455</td><td>1.591</td><td>0.2144</td></tr><tr><td>âhind brake/stride duration</td><td>14.142</td><td>0.831</td><td>15.564</td><td>0.364</td><td>3.373</td><td>0.0737</td></tr><tr><td>âhind step angle</td><td>53.746</td><td>1.757</td><td>55.321</td><td>1.627</td><td>0.338</td><td>0.564</td></tr><tr><td>âhind paw angle</td><td>â0.788</td><td>0.953</td><td>â0.983</td><td>0.519</td><td>0.038</td><td>0.8471</td></tr><tr><td colspan="7">Barnes maze</td></tr><tr><td>âtime spent around target (probe test, 1Â day)</td><td>40.538</td><td>4.748</td><td>39.143</td><td>4.067</td><td>0.042</td><td>0.8385</td></tr><tr><td>âtime spent around target (probe test, 1Â month)</td><td>32.154</td><td>5.78</td><td>30.172</td><td>4.224</td><td>0.072</td><td>0.7904</td></tr><tr><td>âtime spent around target (reversal test, 1Â day)</td><td>31.077</td><td>4.118</td><td>28.214</td><td>3.227</td><td>0.27</td><td>0.6064</td></tr><tr><td colspan="7">Cued and contextual fear conditioning</td></tr><tr><td>âconditioning (freezing, %)</td><td>57.756</td><td>2.66</td><td>56.821</td><td>1.83</td><td>0.82</td><td>0.7764</td></tr><tr><td>âcontext test, 1Â day (freezing, %)</td><td>70.082</td><td>3.444</td><td>66.333</td><td>3.372</td><td>0.453</td><td>0.5053</td></tr><tr><td>âcued test, with tone,1Â day (freezing, %)</td><td>89.158</td><td>3.641</td><td>88.147</td><td>2.004</td><td>0.069</td><td>0.7945</td></tr><tr><td>âcontext test, 30Â days (freezing, %)</td><td>79.412</td><td>5.225</td><td>79.481</td><td>3.222</td><td>0.0001376</td><td>0.9907</td></tr><tr><td>âcued test, pretone period, 30Â days (freezing, %)</td><td>60.603</td><td>4.475</td><td>49.672</td><td>4.306</td><td>2.345</td><td>0.1342</td></tr><tr><td>âcued test, with tone, 30Â days (freezing, %)</td><td>90.183</td><td>3.079</td><td>87.86</td><td>1.944</td><td>0.425</td><td>0.5186</td></tr><tr><td colspan="7">Tail suspension</td></tr><tr><td>âimmobility (%)</td><td>37.255</td><td>3.747</td><td>41.75</td><td>2.603</td><td>0.957</td><td>0.334</td></tr><tr><td colspan="7">24Â h home cage monitoring</td></tr><tr><td>âactivity light period (A.U.)</td><td>478,882.065</td><td>30,477.038</td><td>670,800.611</td><td>107,540.908</td><td>2.948</td><td>0.1167</td></tr><tr><td>âactivity dark period (A.U.)</td><td>1,033,998.833</td><td>66,355.759</td><td>1,385,925</td><td>191,066.128</td><td>3.027</td><td>0.1125</td></tr><tr><td>ânumber of particle dark period</td><td>1.175</td><td>0.02</td><td>1.196</td><td>0.022</td><td>0.482</td><td>0.5034</td></tr><tr><td rowspan="2"></td><td colspan="2">Stranger</td><td colspan="2">Empty or Familiar</td><td>t value</td><td>
<italic>p</italic> value (paired-t)</td></tr><tr><td>Mean</td><td>SEM</td><td>Mean</td><td>SEM</td><td></td><td></td></tr><tr><td colspan="7">Social approach test (Stranger vs Empty)</td></tr><tr><td>ânumber of entry around cage (controls)</td><td>9</td><td>1.043</td><td>7.714</td><td>0.952</td><td>1.178</td><td>0.26</td></tr><tr><td>âtime spent around cage (mutants)</td><td>209.241</td><td>12.352</td><td>137.448</td><td>10.928</td><td>0.627</td><td>0.5359</td></tr><tr><td colspan="7">Social novelty preference test (Stranger vs Familiar)</td></tr><tr><td>ânumber of entry around cage (controls)</td><td>8.357</td><td>0.887</td><td>8.786</td><td>1.11</td><td>â0.405</td><td>0.6918</td></tr><tr><td>ânumber of entry around cage (mutants)</td><td>9.862</td><td>0.851</td><td>10.034</td><td>0.863</td><td>â0.16</td><td>0.8742</td></tr><tr><td>âtime spent around cage (controls)</td><td>165.071</td><td>16.433</td><td>148.5</td><td>28.882</td><td>0.435</td><td>0.6708</td></tr><tr><td>âtime spent around cage (mutants)</td><td>175.31</td><td>17.16</td><td>156.379</td><td>13.814</td><td>0.673</td><td>0.5063</td></tr></tbody></table><table-wrap-foot><p>The tests that were significantly different between T1KO and WT are displayed in Fig.Â <xref ref-type="fig" rid="Fig4">4</xref>. The results of the tests that were not significantly different are listed here. Each group was composed of 20 male mice at the age of 12Â weeks</p></table-wrap-foot></table-wrap>
</p>
</sec>
</sec>
<sec id="Sec5">
<title>Discussion</title>
<p id="Par12">Here, we showed both biochemical (Fig.Â <xref ref-type="fig" rid="Fig1">1</xref>; TableÂ <xref ref-type="table" rid="Tab1">1</xref>) and histochemical results (Figs.Â <xref ref-type="fig" rid="Fig2">2</xref> and <xref ref-type="fig" rid="Fig3">3</xref>) demonstrating reduced CS in various areas of the T1KO brain. Histochemical results also revealed that the CS reduction was in PNNs of the various T1KO regions in brain, in the absence of a change in the amount of AGR (Figs.Â <xref ref-type="fig" rid="Fig2">2</xref> and <xref ref-type="fig" rid="Fig3">3</xref>). In addition, several types of mouse behaviors were significantly abnormal in T1KO (Fig.Â <xref ref-type="fig" rid="Fig4">4</xref>), suggesting that these tests may reflect CS- and PNN-dependent changes. Regarding the CSPG species, we should consider membrane-bound proteins, such as receptor protein phosphatases [<xref ref-type="bibr" rid="CR10">10</xref>]. However, the total amount of CSPG species is likely considerably less than those of PNNs, considering the large space occupied by the extracellular matrix. Thus, our demonstration that T1KO have reduced PNNs is important.</p>
<p id="Par13">Reductions in CS by at least 50% were observed in various T1KO brain regions, suggesting that T1 is an important enzyme responsible for CS synthesis (Fig.Â <xref ref-type="fig" rid="Fig1">1</xref>; TableÂ <xref ref-type="table" rid="Tab1">1</xref>), although five other enzymes with similar substrate specificities were reported [<xref ref-type="bibr" rid="CR10">10</xref>]. As far as we know, this is the first example of genetically targeted mice that showed a 50% loss in the total amount of CS. These results support the hypothesis that T1 is the most important enzyme for CS synthesis in the brain.</p>
<p id="Par14">In addition, the CS-E ratios slightly but significantly increased in cerebrum and diencephalon of T1KO (TableÂ <xref ref-type="table" rid="Tab1">1</xref>). The exact reason of this change is not clearly known, however, it is likely that loss of T1 affects the following sulfation processes by sulfatases [<xref ref-type="bibr" rid="CR10">10</xref>]. In PNNs, CS-E is reported to be involved in association of semaphorin-3A [<xref ref-type="bibr" rid="CR11">11</xref>], not only quantitative decrease but also such qualitative changes of PNNs may have some effects on the behavioral abnormalities (Fig.Â <xref ref-type="fig" rid="Fig4">4</xref>).</p>
<p id="Par15">We also showed that T1KO generally had reduced WFA (+) PNNs in various brain areas, although the decrease was somewhat variable (Figs.Â <xref ref-type="fig" rid="Fig2">2</xref> and <xref ref-type="fig" rid="Fig3">3</xref>). Thus, T1-dependent synthesis of CS is more prevalent in PNNs. In such cases, we did not detected abnormalities of the typical CSPG core protein, AGR, or another glycosaminoglycan, hyaluronic. These results suggest selective reduction of CS chains in PNNs in T1KO.</p>
<p id="Par16">T1 enzyme deficiency caused behavioral abnormalities including abnormalities in the open field test, social interaction test, and acoustic startle response (Fig.Â <xref ref-type="fig" rid="Fig4">4</xref>). These results suggest that CS reduction in PNNs by T1 loss caused abnormalities in higher brain functions and hyperlocomotive activity in mice. These effects are thought to be due to an increase in excitability induced by impaired GABAergic functions [<xref ref-type="bibr" rid="CR12">12</xref>]. In addition, Ito et al. reported that chronic stress inhibits GABAergic signaling [<xref ref-type="bibr" rid="CR12">12</xref>]. Thus, although the exact relationship between each behavioral abnormality and reduced CS in PNNs is not fully understood, one possibility is that the balance in excitatory (glutamatergic) and inhibitory (GABAergic) inputs is shifted in abnormal PNNs, because in various regions, the functions of PV(+) cells which are known to be GABAergic interneurons, are regulated by PNN activity [<xref ref-type="bibr" rid="CR13">13</xref>].</p>
<p id="Par17">It is also recently reported that decreased GABAergic functions induce the sociability [<xref ref-type="bibr" rid="CR14">14</xref>], which may be involved in the changes of our results concerning social interaction and preference (Fig.Â <xref ref-type="fig" rid="Fig4">4e-f</xref>), as models of human autism-spectrum and schizophrenia [<xref ref-type="bibr" rid="CR15">15</xref>â<xref ref-type="bibr" rid="CR17">17</xref>].</p>
<p id="Par18">In our adult T1KO, fear conditioning memories were not significantly impaired (Fig.Â <xref ref-type="fig" rid="Fig4">4</xref>), in contrast to a previous report in which loss of CS in PNNs by chondroitinâs ABC (ChABC) erased these memories in mice younger than 3Â weeks [<xref ref-type="bibr" rid="CR18">18</xref>]. Such a âcritical periodâ in mice may have different mechanisms in adult vs. juvenile mice [<xref ref-type="bibr" rid="CR19">19</xref>]. Using these same T1KO, we recently showed that ocular dominance plasticity in the critical period was severely impaired after monocular deprivation, probably due to reduced function of PV (+) cells in the visual cortex [<xref ref-type="bibr" rid="CR20">20</xref>]. In mice aged 3Â weeks for these experiments, AGR and PV (+) cells were reduced, together with CS in PNNs in the visual cortex [<xref ref-type="bibr" rid="CR20">20</xref>], which is different from our current results in adult mice (Figs.Â <xref ref-type="fig" rid="Fig2">2</xref> and <xref ref-type="fig" rid="Fig3">3</xref>). As shown in Figs.Â <xref ref-type="fig" rid="Fig2">2</xref> and <xref ref-type="fig" rid="Fig3">3</xref>, some of these morphological abnormalities were observed and some were not. Taken together, T1KO may have additional behavioral abnormalities in the developmental stage, and may be a good model for studies of PNN-dependent neural plasticity. A report that the good results of open filed tests as higher brain functions, after learning, are reported to induce the increase of PNNs [<xref ref-type="bibr" rid="CR21">21</xref>], seems related to our results (Fig.Â <xref ref-type="fig" rid="Fig4">4c</xref>).</p>
<p id="Par19">Consistent with the above mention of chronic stress [<xref ref-type="bibr" rid="CR12">12</xref>], PNNs may be also involved in human psychiatric disorders [<xref ref-type="bibr" rid="CR22">22</xref>], and this idea should be confirmed using an appropriate animal model for PNNs. However, until now, only the ChABC-treated mouse model represented decreased PNNs. The problem with this acute model for inducing PNN abnormalities is that the extent of the decreases in CS in PNNs and how long this effect is maintained are unknown. In contrast, our T1KO mice quantitatively exhibited a 50% reduction in CS (Fig.Â <xref ref-type="fig" rid="Fig1">1</xref>) and a decrease in CS in PNNs, but the absence of a decrease in AGR (+) area or PV (+) cells (Figs.Â <xref ref-type="fig" rid="Fig2">2</xref> and <xref ref-type="fig" rid="Fig3">3</xref>). Thus, T1KO may be a better model for abnormal PNNs than ChABC-treated mice. Recently, in the KO of a link protein Bral2, a component of PNNs, abnormal acoustic startle tests are reported [<xref ref-type="bibr" rid="CR23">23</xref>], may support our results (Fig.Â <xref ref-type="fig" rid="Fig4">4d</xref>).</p>
<p id="Par20">Taken together, we conclude that T1 is the most important factor that controls CS-dependent brain functions. In addition, T1KO may be the most suitable genetic model for studying the functions of PNNs. To further examine the mechanism of CS synthesis and its biological significance, we are planning to analyze mice that are null for CSGalNAcT2 (T2), which is the other isoform of T1, and/or conditional T1/T2 KO mice. For example, most learning and memory tests in T1KO did not show a significant difference from WT, probably because they are dependent upon hippocampal activity [<xref ref-type="bibr" rid="CR15">15</xref>]. In T1KO, hippocampal PNNs were significantly but only slightly reduced compared to PNNs in other brain regions (Figs.Â <xref ref-type="fig" rid="Fig2">2</xref> and <xref ref-type="fig" rid="Fig3">3</xref>). T1/T2 double knockouts will probably be embryonic lethal due to induction of skeletal defects (M.I., in preparation). However, using T2KO, T1KO/T2 heterozygotes, and T1 heterozygotes/T2KO, larger effects of decreased CS in PNNs are expected.</p>
</sec>
<sec id="Sec6">
<title>Methods</title>
<sec id="Sec7">
<title>Animals</title>
<p id="Par21">T1KO, T1 heterozygotes, and WT littermates on the C57BL/6 background were maintained [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Four T1KO or four WT mice were housed per cage, and the mice were group-housed in a room with a 12-h light/dark cycle.</p>
</sec>
<sec id="Sec8">
<title>Quantitative biochemical analysis of CS</title>
<p id="Par22">Purification and quantification of CS in various areas of the brain were performed as described previously [<xref ref-type="bibr" rid="CR9">9</xref>]. In brief, the mice were sacrificed by decapitation. Various regions of the adult mouse brain were dissected, homogenized, and treated with protease (0.01Â mg actinase E, 10Â mM CaCl<sub>2</sub>, 50Â mM Tris-HCl, pHÂ 8.0) for 2Â days at 55Â Â°C. After trichloroacetic acid treatment, the supernatant was gel filtered (Sephadex G-25, 8.3Â ml (PD-10 column), and the flow-through fractions were collected. To analyze the disaccharide composition, fractions were treated with ChABC (5 mIU ChABC in 60Â mM CH<sub>3</sub>COONa, 50Â mM Tris-HCl, pHÂ 8.0) for 12Â h at 37Â Â°C. The disaccharides were labeled with 2-aminobenzamide (350Â mM 2-aminobenzamide, 1Â M NaCNBH<sub>3</sub> in DMSO/acetic acid (7:3)) for 2Â h at 65Â Â°C and analyzed quantitatively using high-performance liquid chromatography (column: YMC pack PA, 4.6Â ÃÂ 250Â mm, elution: 16â530Â mM NaH<sub>2</sub>PO<sub>4</sub>, flow rate: 1Â ml/min; detection: 330Â nm excitation and 420Â nm emission). The disaccharide analysis data are shown in TableÂ <xref ref-type="table" rid="Tab1">1</xref>.</p>
</sec>
<sec id="Sec9">
<title>Histochemistry and immunohistochemistry</title>
<p id="Par23">Histological procedures were carried out according to previously described methods [<xref ref-type="bibr" rid="CR24">24</xref>]. Antibodies against AGR (rabbit polyclonal) and PV (mouse monoclonal) were purchased from Millipore, and from Swant Inc. (Switzerland), respectively. For tissue preparation, under deep anesthesia with isoflurane, the brain was fixed by cardiac perfusion with PBS followed by ice-cold 4% paraformaldehyde in 0.1Â M phosphate buffer, pHÂ 7.4. The brain was dissected out, immersed in the same fixative overnight, and transferred to 20% sucrose in 20Â mM PBS, pHÂ 7.4 until it sank. Each brain was frozen in crushed dry ice, and 30Â Î¼m-thick consecutive coronal sections were cut on a cryostat and stored at â20Â Â°C until histological staining.</p>
<p id="Par24">Sections were initially rinsed in 20Â mM PBS and incubated in 0.1% Triton X-100 for 15Â min at room temperature. After rinsing in 20Â mM PBS, the sections were incubated overnight at 4Â Â°C with a mixture of biotinylated-WFA (Sigma-Aldrich) and primary antibodies diluted with 20Â mM PBS containing 0.5% skim milk. After rinsing in 20Â mM PBS for 15Â min, sections were incubated with a mixture of streptavidin-Alexa FluorÂ® 647 conjugate (1:100; Molecular Probes, Inc., Eugene, OR) and secondary antibodies conjugated to Alexa FluorÂ®488 or Alexa FluorÂ®594 (1:100; Jackson ImmunoResearch Laboratories, West Grove, PA) for 60Â min at 37Â Â°C. After rinsing with 20Â mM PBS for 15Â min, sections were mounted on MASÂ®-coated glass slides (Matsunami Glass, Osaka, Japan) and coverslipped with ProLong Gold (Molecular Probes). Sections were observed and digital images were recorded on a confocal laser scanning microscope (FV-1200, Olympus, Tokyo, Japan). TIF files were processed with Photoshop software (Adobe, San Jose, CA). Both brightness and background were adequately adjusted.</p>
<p id="Par25">For DAB staining, free-floating sections were initially rinsed in 20Â mM PBS and incubated in a mixture of 3% hydrogen peroxide and 0.1% Triton X-100 for 15Â min at room temperature. 2H6 (Seikagaku Corporation, Tokyo, Japan) was diluted in 20Â mM PBS containing 0.5% skim milk. For 2H6 staining, following rinsing in 20Â mM PBS for 15Â min, sections were incubated with biotinylated anti-mouse IgM secondary antibody (1:200; Vector Laboratories, Burlingame, CA) for 30Â min at 37Â Â°C. After rinsing with 20Â mM PBS for 15Â min, sections were incubated in avidin-biotin peroxidase complex (Vectastain ABC kit, Vector Laboratories) for 30Â min (2H6) or 60Â min (WFA) at 37Â Â°C. After rinsing with 20Â mM PBS, immunoreaction was visualized in 50Â mM Tris-HCl buffer (pHÂ 7.4) containing 0.01% DAB and 0.01% hydrogen peroxide at 37Â Â°C for 5â10Â min. Sections were mounted on MAS-coated glass slides (Matsunami Glass), air-dried on a hot plate at 40Â Â°C, and coverslipped with Entellan Neu (Merck, Darmstadt, Germany) after dehydration through ethanol and xylene.</p>
<p id="Par26">Dilution ratios: were as follows: WFA, 1:50; 2H6, 1:100; anti-PV, 1:500; and anti-AGR, 1:500.</p>
</sec>
<sec id="Sec10">
<title>Quantitative morphometry</title>
<p id="Par27">We initially counted the number of PV (+) cells. However, that method was not suitable for exact quantification of PV (+) cells because the staining of PV (+) cells varied widely. Thus, we switched to the following quantification methods. The fluorescent intensity of the immunohistochemical and WFA histochemical images was statistically calculated using Image J. Double- (AGR and WFA) or triple (AGR, WFA, and PV)-labeled confocal images were used for the intensity analysis. AGR+ pixels were extracted by masking with an intensity threshold (&gt;50). The average intensity of the AGR+ pixels was calculated for each AGR, WFA, or PV image. The average intensity data were grouped by genotype and brain area. Two-way factorial ANOVA with Bonferroni post-hoc tests were performed for statistical analysis.</p>
</sec>
<sec id="Sec11">
<title>Animal behavioral tests</title>
<p id="Par28">A battery of mouse behavioral tests was done as described previously [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. All behavioral tests were carried out with male mice. A general health check and neurological screen were conducted as previously described [<xref ref-type="bibr" rid="CR27">27</xref>]. The order in which mice were subjected to tests was counterbalanced. Raw data were disclosed in the Mouse Phenotype Database (<ext-link ext-link-type="uri" xlink:href="http://www.mouse-phenotype.org/">http://www.mouse-phenotype.org/</ext-link>). T1KO and WT mice (<italic>n</italic>Â =Â 20 each) at 8Â weeks of age were tested. The tests that showed statistically significant differences in T1KO vs. WT were:</p>
<p id="Par29">(I) Open field test: This test was performed to evaluate locomotor activity and emotional response [<xref ref-type="bibr" rid="CR21">21</xref>]. The apparatus was a transparent square cage (42Â ÃÂ 42Â ÃÂ 30Â cm; Accuscan Instruments, Columbus, OH). The center of the floor was illuminated at 100Â lx. Each mouse was placed in the open field apparatus and recorded for 120Â min. Total distance traveled (cm), vertical activity (rearing measured by counting the number of photobeam interruptions), time spent in the center area (20Â ÃÂ 20Â cm), and the beam-break counts for stereotyped behaviors were measured.</p>
<p id="Par30">(II) Social interaction test in a novel environment [<xref ref-type="bibr" rid="CR27">27</xref>]: Two mice of the same genotype that were previously housed in different cages were placed in a box together (40Â ÃÂ 40Â ÃÂ 30Â cm; OâHara &amp; Co., Tokyo, Japan) and allowed to explore freely for 10Â min. Mouse behavior was analyzed automatically using ImageSI software. The total duration of contacts (s), number of contacts, total duration of active contacts (s), mean duration per contact (s), and total distance traveled (cm) were measured. Active contact was defined as follows: images were captured at three frames per second, and distance traveled between two successive frames was calculated for each mouse. If the two mice contacted each other and the distance traveled by either mouse was 5Â cm or more, the behavior was considered an âactive contact.â</p>
<p id="Par31">(III) Three-chambered social approach test: The test for sociability and social novelty preference was conducted as previously described [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. For habituation to the test environment, stranger mice were placed in a small cylindrical cage with vertical bars that was put in a corner of the chamber prior to the test. Test mice were placed in the middle chamber and allowed to explore and habituate to the chambers for 10Â min just before the first session. In the first session, an unfamiliar mouse (stranger 1) was put in the cage and placed in a corner of the left or right side chamber. The selection of the left or right side chamber was counterbalanced across test mice. An empty cage was placed in the corner of the other chamber. Then the test mouse was placed in the middle chamber and allowed to explore the three chambers for 10Â min. In the second session, another unfamiliar mouse (stranger 2) was placed in the cage that had been empty during the first session. Then the test mouse was placed in the middle chamber and allowed to explore for 10Â min. Total distance travelled, average locomotion speed, and the amount of time spent around the cages were measured. Data acquisition and analysis were performed automatically using ImageSI.</p>
<p id="Par32">(IV) Startle response/prepulse inhibition test: A startle reflex measurement system (OâHara &amp; Co.) was used to measure startle response to a loud noise and prepulse inhibition of the startle response. A test session began by placing a mouse in a plastic cylinder where it was left undisturbed for 10Â min. White noise (40Â ms) was used as the startle stimulus for all trial types. The startle response was recorded for 400Â ms starting with the onset of the startle stimulus. The background noise level was 70Â dB. The peak startle amplitude was the dependent variable. A test session consisted of six trial types (e.g., two types of startle-stimulus-only trials, and four types for prepulse inhibition trials). The intensity of the startle stimulus was either 110 or 120Â dB. The prepulse sound was presented 100Â ms before the onset of the startle stimulus, and its intensity was 74 or 78Â dB (20Â ms). Four combinations of prepulse and startle stimuli were used (74â110, 78â110, 74â120, and 78â120Â dB). Six blocks of the six trial types were presented in a pseudorandom order such that each trial type was presented once within a block. The average inter-trial interval was 15Â s (range: 10â20Â s). Behavioral tests that were not significantly different between genotypes are listed in TableÂ <xref ref-type="table" rid="Tab2">2</xref>. Behavioral data were obtained automatically by applications (ImageLD, EP, SI, CSI, PS, FZ, TS, HCSI, and BM) based on the public domain Image J program (<ext-link ext-link-type="uri" xlink:href="http://rsb.info.nih.gov/ij">http://rsb.info.nih.gov/ij/</ext-link>) and modified for each test by the authors. Statistical analysis was conducted using StatView (SAS Institute, Cary, NC). Data were analyzed with the Studentâs <italic>t</italic>-test, paired <italic>t</italic>-test, one-way ANOVA, or two-way repeated measures ANOVA. Values in graphs are presented as the meanÂ Â±Â SEM.</p>
</sec>
</sec>
</body>
<back>
<app-group>
<app id="App1">
<sec id="Sec12">
<title>Additional file</title>
<p id="Par39">
<media id="MOESM1" position="anchor" xlink:href="13041_2017_328_MOESM1_ESM.jpg"><label>Additional file 1: Figure S1.</label><caption><p>Western blotting analysis of AGR in adult brains of WT and T1KO (<italic>KO</italic>). Brain homogenates prepared from 12-w male mice were subjected to SDS-PAGE and the western blotting was detected using anti-AGR (1:500). Note that the amounts of AGR were not changed in WT and in T1KO. The molecular masses (kDa) are shown in the left. (JPEG 52 kb)</p></caption></media>
</p>
</sec>
</app>
</app-group>
<fn-group>
<fn>
<p>
<bold>Electronic supplementary material</bold>
</p>
<p>The online version of this article (10.1186/s13041-017-0328-5) contains supplementary material, which is available to authorized users.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>We thank Y. Wada (Igarashi lab) for her technical assistance and the Animal Resource Department of Niigata University for production and maintenance of T1KO.</p>
<sec id="FPar1">
<title>Funding</title>
<p id="Par33">This work was supported in part by TOGO-NO and HOKATSU-NO (Comprehensive Brain Science Network) on Innovative Areas (to M.I.), Project Promoting Grants from Niigata University, Uehara Memorial Science Promoting Foundation (to M.I.), RIKEN BRC Grants for gene targeting in mice (to M.I.), KAKENHI (#17023019, #22240040, and #24111515 to M.I) from MEXT of Japan and JSPS, Platform of Advanced Animal Model Support from MEXT of Japan (to M.I., K.T., and T.M), and Sasakawa Scientific Research Grant from The Japan Science Society (to N.Y.).</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p id="Par34">The datasets supporting the conclusion of this study are included in this article.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authorsâ Contributions</title>
<p>MI, NY, and KT designed the experiments. SM and HK quantitatively analyzed the CS biochemical data. NY and KT performed the histochemical analysis; NY and AT quantified these results. YW and AK produced and maintained T1KO. TK and TM designed the behavioral test battery, and TK performed the tests. MI, NY, AT, and AK wrote the paper. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar3">
<title>Ethics approval</title>
<p id="Par35">Not applicable.</p>
</sec>
<sec id="FPar4">
<title>Consent for publication</title>
<p id="Par36">Not applicable.</p>
</sec>
<sec id="FPar5">
<title>Competing interests</title>
<p id="Par37">The authors declare that they have no competing interests.</p>
</sec>
<sec id="FPar6">
<title>Publisherâs Note</title>
<p id="Par38">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sugiyama</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Di Nardo</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Aizawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Matsuo</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Volovitch</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Prochiantz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hensch</surname>
<given-names>TK</given-names>
</name>
</person-group>
<article-title>Experience-dependent transfer of Otx2 homeoprotein into the visual cortex activates postnatal plasticity</article-title>
<source/>Cell
          <year>2008</year>
<volume>134</volume>
<fpage>508</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2008.05.054</pub-id>
<pub-id pub-id-type="pmid">18692473</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsien</surname>
<given-names>RY</given-names>
</name>
</person-group>
<article-title>Very long-term memories may be stored in the pattern of holes in the perineuronal net</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2013</year>
<volume>110</volume>
<fpage>12456</fpage>
<lpage>12461</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1310158110</pub-id>
<pub-id pub-id-type="pmid">23832785</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fawcett</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>The extracellular matrix in plasticity and regeneration after CNS injury and neurodegenerative disease</article-title>
<source/>Prog Brain Res
          <year>2015</year>
<volume>218</volume>
<fpage>213</fpage>
<lpage>226</lpage>
<pub-id pub-id-type="doi">10.1016/bs.pbr.2015.02.001</pub-id>
<pub-id pub-id-type="pmid">25890139</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<mixed-citation publication-type="other">Hunter AM, Leuchter AF, Power RA, MuthÃ©n B, McGrath PJ, Lewis CM, Cook IA, Garriock HA, McGuffin P, Uher R, Hamilton SP. A genome-wide association study of a sustained pattern of antidepressant response. J Psychiatr Res 2013; 47: 1157-1165. 5.</mixed-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bitanihirwe</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Woo</surname>
<given-names>TU</given-names>
</name>
</person-group>
<article-title>Perineuronal nets and schizophrenia: the importance of neuronal coatings</article-title>
<source/>Neurosci Biobehav Rev
          <year>2014</year>
<volume>45</volume>
<fpage>85</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2014.03.018</pub-id>
<pub-id pub-id-type="pmid">24709070</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Do</surname>
<given-names>KQ</given-names>
</name>
<name>
<surname>Cuenod</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hensch</surname>
<given-names>TK</given-names>
</name>
</person-group>
<article-title>Targeting oxidative stress and aberrant critical period plasticity in the developmental trajectory to schizophrenia</article-title>
<source/>Schizophr Bull
          <year>2015</year>
<volume>41</volume>
<fpage>835</fpage>
<lpage>846</lpage>
<pub-id pub-id-type="doi">10.1093/schbul/sbv065</pub-id>
<pub-id pub-id-type="pmid">26032508</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Takeuchi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Higa Onaga</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tsujita</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Natsume</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Furuichi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Saeki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Izumikawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ikegawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sakimura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Amizuka</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kitagawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Igarashi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Chondroitin sulfate <italic>N</italic>-acetylgalactosaminyltransferase-1 is required for normal cartilage development</article-title>
<source/>Biochem J
          <year>2010</year>
<volume>432</volume>
<fpage>47</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="doi">10.1042/BJ20100847</pub-id>
<pub-id pub-id-type="pmid">20812917</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sato</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kudo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ikehara</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ogawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hirano</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kiyohara</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hagiwara</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Togayachi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ema</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kimata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Narimatsu</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Chondroitin sulfate <italic>N</italic>-acetylgalactosaminyltransferase 1 is necessary for normal endochondral ossification and aggrecan metabolism</article-title>
<source/>J Biol Chem
          <year>2011</year>
<volume>286</volume>
<fpage>5803</fpage>
<lpage>5812</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M110.159244</pub-id>
<pub-id pub-id-type="pmid">21148564</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takeuchi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yoshioka</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Higa Onaga</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Miyata</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wada</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kudo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ohko</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Oda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Matsushita</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Okano</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sakimura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kawano</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kitagawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Igarashi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Chondroitin sulphate <italic>N</italic>-acetylgalactosaminyl-transferase-1 inhibits recovery from neural injury</article-title>
<source/>Nat Commun
          <year>2013</year>
<volume>4</volume>
<fpage>2740</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms3740</pub-id>
<pub-id pub-id-type="pmid">24220492</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mikami</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kitagawa</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Biosynthesis and function of chondroitin sulfate</article-title>
<source/>Biochim Biophys Acta
          <year>1830</year>
<volume>2013</volume>
<fpage>4719</fpage>
<lpage>4733</lpage>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dick</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Alves</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Ehlert</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Hsieh-Wilson</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Sugahara</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Oosterhof</surname>
<given-names>A</given-names>
</name>
<name>
<surname>van Kuppevelt</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Verhaagen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fawcett</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Kwok</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Semaphorin 3A binds to the perineuronal nets via chondroitin sulfate type E motifs in rodent brains</article-title>
<source/>J Biol Chem
          <year>2013</year>
<volume>288</volume>
<fpage>27384</fpage>
<lpage>27395</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M111.310029</pub-id>
<pub-id pub-id-type="pmid">23940048</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ito</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nagano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Murakoshi</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Chronic stress enhances synaptic plasticity due to disinhibition in the anterior cingulate cortex and induces hyper-locomotion in mice</article-title>
<source/>Neuropharmacology
          <year>2010</year>
<volume>58</volume>
<fpage>746</fpage>
<lpage>757</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2009.12.011</pub-id>
<pub-id pub-id-type="pmid">20035774</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jonas</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Interneurons. Fast-spiking, parvalbumin<sup>+</sup> GABAergic interneurons: from cellular design to microcircuit function</article-title>
<source/>Science
          <year>2014</year>
<volume>345</volume>
<fpage>1255263</fpage>
<pub-id pub-id-type="doi">10.1126/science.1255263</pub-id>
<pub-id pub-id-type="pmid">25082707</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paine</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Swedlow</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Swetschinski</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Decreasing GABA function within the medial prefrontal cortex or basolateral amygdala decreases sociability</article-title>
<source/>Behav Brain Res
          <year>2017</year>
<volume>317</volume>
<fpage>542</fpage>
<lpage>552</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2016.10.012</pub-id>
<pub-id pub-id-type="pmid">27732892</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Intrauterine environment-genome interaction and children's development (4): Brain-behavior phenotypying of genetically-engineered mice using a comprehensive behavioral test battery on research of neuropsychiatric disorders</article-title>
<source/>J Toxicol Sci
          <year>2009</year>
<volume>34</volume>
<fpage>SP293</fpage>
<lpage>SP305</lpage>
<pub-id pub-id-type="doi">10.2131/jts.34.SP293</pub-id>
<pub-id pub-id-type="pmid">19571483</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pantazopoulos</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Berretta</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>In Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric Disorders</article-title>
<source/>Neural Plast
          <year>2016</year>
<volume>2016</volume>
<fpage>9847696</fpage>
<pub-id pub-id-type="doi">10.1155/2016/9847696</pub-id>
<pub-id pub-id-type="pmid">26839720</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>TB</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>LG</given-names>
</name>
</person-group>
<article-title>Behavioral Phenotyping for Autism Spectrum Disorders in Mice</article-title>
<source/>Curr Protoc Toxicol
          <year>2017</year>
<volume>72</volume>
<fpage>11.22.1</fpage>
<lpage>11.22.21</lpage>
<pub-id pub-id-type="doi">10.1002/cptx.19</pub-id>
<pub-id pub-id-type="pmid">28463420</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gogolla</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Caroni</surname>
<given-names>P</given-names>
</name>
<name>
<surname>LÃ¼thi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Herry</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Perineuronal nets protect fear memories from erasure</article-title>
<source/>Science
          <year>2009</year>
<volume>325</volume>
<fpage>1258</fpage>
<lpage>1261</lpage>
<pub-id pub-id-type="doi">10.1126/science.1174146</pub-id>
<pub-id pub-id-type="pmid">19729657</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>A developmental dissociation of context and GABA effects on extinguished fear in rats</article-title>
<source/>Behav Neurosci
          <year>2007</year>
<volume>121</volume>
<fpage>131</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="doi">10.1037/0735-7044.121.1.131</pub-id>
<pub-id pub-id-type="pmid">17324057</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<mixed-citation publication-type="other">Hou X, Yoshioka N, Tsukano H, Sakai A, Miyata S, Watanabe Y, Yanagawa Y, Sakimura K, Takeuchi K, Kitagawa H, Hensch TK, Shibuki K, Igarashi M, Sugiyama S. Chondroitin sulfate is required for onset and offset of critical period plasticity in visual cortex. SciRep. 2017; in press</mixed-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simonetti</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bourke</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Leamey</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Sawatari</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Enrichment from birth accelerates the functional and cellular development of a motor control area in the mouse</article-title>
<source/>PLoS One
          <year>2009</year>
<volume>4</volume>
<fpage>e6780</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0006780</pub-id>
<pub-id pub-id-type="pmid">19756157</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avram</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shaposhnikov</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Buiu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mernea</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Chondroitin sulfate proteoglycans: structure-function relationship with implication in neural development and brain disorders</article-title>
<source/>Biomed Res Int
          <year>2014</year>
<volume>2014</volume>
<fpage>642798</fpage>
<pub-id pub-id-type="doi">10.1155/2014/642798</pub-id>
<pub-id pub-id-type="pmid">24955366</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<mixed-citation publication-type="other">PopelÃ¡Å J, DÃ­az GÃ³mez M, LindovskÃ½ J, Rybalko N, BurianovÃ¡ J, Oohashi T, Syka J. The absence of brain-specific link protein Bral2 in perineuronal nets hampers auditory temporal resolution and neural adaptation in mice. Physiol Res. 2017; in press (Jul 18. [Epub ahead of print]).</mixed-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshioka</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Asou</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hisanaga</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kawano</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The astrocytic lineage marker calmodulin-regulated spectrin-associated protein 1 (Camsap1): phenotypic heterogeneity of newly born Camsap1-expressing cells in injured mouse brain</article-title>
<source/>J Comp Neurol
          <year>2012</year>
<volume>520</volume>
<fpage>1301</fpage>
<lpage>1317</lpage>
<pub-id pub-id-type="doi">10.1002/cne.22788</pub-id>
<pub-id pub-id-type="pmid">22095662</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamasaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Impact of brain-behavior phenotypying of genetically-engineered mice on research of neuropsychiatric disorders</article-title>
<source/>Neurosci Res
          <year>2007</year>
<volume>58</volume>
<fpage>124</fpage>
<lpage>132</lpage>
<pub-id pub-id-type="doi">10.1016/j.neures.2007.02.009</pub-id>
<pub-id pub-id-type="pmid">17524507</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Katayama</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Takeuchi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Togano</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Itoh</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yamazaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Oda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Takao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fukaya</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sakimura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Manabe</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Igarashi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Point mutation in syntaxin-1A causes abnormal vesicle recycling, behaviors, and short term plasticity</article-title>
<source/>J Biol Chem
          <year>2013</year>
<volume>288</volume>
<fpage>34906</fpage>
<lpage>34919</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M113.504050</pub-id>
<pub-id pub-id-type="pmid">24136198</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shoji</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Takao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hattori</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Age-related changes in behavior in C57BL/6J mice from young adulthood to middle age</article-title>
<source/>Mol Brain
          <year>2016</year>
<volume>9</volume>
<fpage>11</fpage>
<pub-id pub-id-type="doi">10.1186/s13041-016-0191-9</pub-id>
<pub-id pub-id-type="pmid">26822304</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prut</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Belzung</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review</article-title>
<source/>Eur J Pharmacol
          <year>2003</year>
<volume>463</volume>
<fpage>3</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1016/S0014-2999(03)01272-X</pub-id>
<pub-id pub-id-type="pmid">12600700</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tanda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kasahara</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nakao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Katsuki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nakanishi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamasaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Toyama</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Adachi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Umeda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Araki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Fukunaga</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sakagami</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>() Comprehensive behavioral analysis of calcium/calmodulin-dependent protein kinase IV knockout mice</article-title>
<source/>PLoS One
          <year>2010</year>
<volume>5</volume>
<fpage>e9460</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0009460</pub-id>
<pub-id pub-id-type="pmid">20209163</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>